Holen Sie sich die Stockscreener-App
9.31
1.17%
-0.11
Schlusskurs vom Vortag:
$9.42
Offen:
$9.43
24-Stunden-Volumen:
733.01K
Relative Volume:
0.55
Marktkapitalisierung:
$380.93M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-11.35
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
+4.72%
1M Leistung:
+26.67%
6M Leistung:
-64.29%
1J Leistung:
-82.93%
1-Tages-Spanne:
$9.10
$9.565
1-Wochen-Bereich:
$8.55
$10.25
52-Wochen-Spanne:
$6.32
$57.53
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
9.31 | 409.98M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
RXST Deadline: Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Berger Montague Reminds RxSight, Inc. (NASDAQ: RXST) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by September 22, 2025 - MarketScreener
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
RxSight (NASDAQ:RXST) Upgraded at Zacks Research - MarketBeat
Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - PR Newswire
Hopeful Week For Insiders Who Bought US$1.11m Of RxSight Stock - simplywall.st
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - Louisiana First News
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
RxSight, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - PR Newswire
RXST FRAUD NOTICE: RxSight, Inc. Hit with Securities Class - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RXST LAWSUIT ALERT: The Gross Law Firm Notifies RxSight, - GlobeNewswire
Levi & Korsinsky Urges RxSight, Inc. (RXST) Shareholders to Act Before Lead Plaintiff Deadline September 22, 2025 - ACCESS Newswire
RXST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - Newsfile
RxSight, Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
Northern Trust Corp Buys 35,021 Shares of RxSight, Inc. $RXST - MarketBeat
RXST INVESTOR DEADLINE: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
Is RxSight Inc. a top pick in the sectorJuly 2025 Intraday Action & Stepwise Trade Signal Implementation - Lancaster City Council
Class Action Alert: Levi & Korsinsky Reminds RxSight, Inc. (RXST) Investors of September 22, 2025 Deadline - ACCESS Newswire
Can RxSight Inc. reach all time highs this year2025 Analyst Calls & Verified Trade Idea Suggestions - Lancaster City Council
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Business Wire
Investor Alert: Deadline Approaching to Join RxSight, Inc. (RXST) Class ActionContact Levi & Korsinsky - ACCESS Newswire
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein - GlobeNewswire
DEADLINE APPROACHING: Berger Montague Advises RxSight, Inc. (NASDAQ - MarketScreener
RxSight, Inc. Class Action: Levi & Korsinsky Reminds - GlobeNewswire
How to contact the Daily Bulletin - FinancialContent
RXST LAWSUIT ALERT: The Gross Law Firm Notifies RxSight, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
RXST SHAREHOLDERS: RxSight, Inc. LAL Utilization Decline - GlobeNewswire
Securities Fraud Class Action Filed Against RxSight, Inc. (RXST)Levi & Korsinsky Reminds Investors of September 22, 2025 - ACCESS Newswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been - Bluefield Daily Telegraph
Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky Before September 22, 2025 to Join Class Action - ACCESS Newswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - PR Newswire
Class Action Lawsuit Filed: RxSight, Inc. (RXST)Join by September 22, 2025 – Contact Levi & Korsinsky - ACCESS Newswire
RXST LAWSUIT NOTICE: Lose Money on RxSight, Inc.? Contact - GlobeNewswire
142,036 Shares in RxSight, Inc. $RXST Bought by Armistice Capital LLC - MarketBeat
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - PR Newswire
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Can momentum traders help lift RxSight Inc.2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
RxSight, Inc. Class Action: The Gross Law Firm Reminds - GlobeNewswire
RXST CLASS ALERT: BFA Alerts RxSight, Inc. Investors with - GlobeNewswire
Securities Fraud and Shareholder Risks at RxSight (RXST): Assessing Legal and Financial Implications - AInvest
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. LawsuitRXST - Morningstar
RxSight, Inc. (NASDAQ: RXST) Investor Alert: Deadline in Lawsuit on September 22, 2025 - openPR.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):